Mycobacterium tuberculosis prosthetic joint infections: A case series and literature review - 28/12/18
for the Groupe d'Epidémiologie et Recherche en Infectiologie Clinique Centre-Ouest (GERICCO)
Summary |
Objectives |
We aimed to characterize diagnosis, management, and outcome of Mycobacterium tuberculosis prosthetic joint infections (PJI).
Methods |
Cases of M. tuberculosis PJI documented in 7 referral French centers were retrospectively reviewed. Data were collected from medical files on a standardized questionnaire. We performed a literature review using the keywords ‘prosthetic joint’, and ‘tuberculosis’.
Results |
During years 1997–2016, 13 patients (8 males, 5 females, median age 79 years [range, 60–86]) had documented M. tuberculosis PJI, involving hip (n = 6), knee (n = 6), or shoulder (n = 1). Median time from arthroplasty to diagnosis was 9 years [0.4–20]. The diagnosis was obtained on joint aspirates (n = 9), or synovial tissue (n = 4). PCR was positive in all cases tested (5/5). Median duration of antituberculosis treatment was 14 months [6–32]). Nine patients underwent surgery: debridement (n = 4), resection arthroplasty (n = 3), and revision arthroplasty (1-stage exchange, n = 2). PJI was controlled in 12 patients. Seventeen additional cases of documented M. tuberculosis PJI have been reported, with a favorable outcome in 79% (11/14) of patients with no surgery, 85% (11/13) with debridement, 86% (19/22) with revision arthroplasty, and 81% (17/21) with resection (NS).
Conclusions |
M. tuberculosis PJI can be controlled with prolonged antituberculosis treatment in most cases, with or without surgical treatment.
Le texte complet de cet article est disponible en PDF.Keywords : Prosthetic joint, Mycobacterium tuberculosis, Arthroplasty, Debridement, Antituberculosis drug
Plan
Vol 78 - N° 1
P. 27-34 - janvier 2019 Retour au numéro
Article précédent
- A hand hygiene intervention to decrease hand, foot and mouth disease and absence due to sickness among kindergarteners in China: A cluster-randomized controlled trial
- Xiaona Liu, Wanli Hou, Zhiguang Zhao, Jinquan Cheng, Ed F. van Beeck, Xiaodong Peng, Kylah Jones, Xia Fu, Yan Zhou, Zhen Zhang, Jan Hendrik Richardus, Vicki Erasmus
- Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery
- Sergey E. Borisov, Lia D'Ambrosio, Rosella Centis, Simon Tiberi, Keertan Dheda, Jan-Willem Alffenaar, Rohit Amale, Evgeny Belilowski, Judith Bruchfeld, Barbara Canneto, Justin Denholm, Raquel Duarte, Aliasgar Esmail, Alex Filippov, Lina Davies Forsman, Mina Gaga, Shashank Ganatra, Gaida Anastasia Igorevna, Barbara Lazaro Mastrapa, Vinicio Manfrin, Selene Manga, Andrey Maryandyshev, Gilbert Massard, Pablo González Montaner, Jai Mullerpattan, Domingo Juan Palmero, Agostina Pontarelli, Apostolos Papavasileiou, Emanuele Pontali, Rodolfo Romero Leyet, Antonio Spanevello, Zarir Farokh Udwadia, Pietro Viggiani, Dina Visca, Giovanni Sotgiu, Giovanni Battista Migliori
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?